Raymond K. Cross
6 Podcast Episodes
Raymond K. Cross, Jr., MD, MS: Biosimilars in IBD: Where Do We Stand Today?
Raymond K. Cross, Jr., MD, MS: Biosimilars in IBD: Where Do We Stand Today?
Webcast: Optimizing Biological and Biosimilar Therapies in the Modern Era
22 Dec 2018
•
16mins
Raymond K. Cross, Jr., MD, MS: Biosimilars in IBD: Where Do We Stand Today?
Raymond K. Cross, Jr., MD, MS: Biosimilars in IBD: Where Do We Stand Today?
Webcast: Optimizing Biological and Biosimilar Therapies in the Modern Era
22 Dec 2018
•
16mins
Similar People
Sonia Friedman
Robert Sidbury
Jonathan Kay
Richard Kim
Stanley Cohen
Matt S
Atopic Dermatitis
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Heinz-Josef Lenz
Rakesh Jain
Josep Tabernero
Jean-Yves Douillard
John Cooper
Raymond K. Cross, Jr., MD, MS: Rheumatologic and autoimmune diseases
Raymond K. Cross, Jr., MD, MS: Rheumatologic and autoimmune diseases
Webcast: Advances in IBD 2018 - Clinical Track
21 Dec 2018
•
18mins
Raymond K. Cross, Jr., MD, MS: Rheumatologic and autoimmune diseases
Raymond K. Cross, Jr., MD, MS: Rheumatologic and autoimmune diseases
Webcast: Advances in IBD 2018 - Clinical Track
21 Dec 2018
•
18mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Raymond K. Cross, MD, MS: Case Discussion: The Moderate-to-severe CD patient: What are the options and where do new therapies including biosimilars fit in the picture?
Raymond K. Cross, MD, MS: Case Discussion: The Moderate-to-severe CD patient: What are the options and where do new therapies including biosimilars fit in the picture?
Webcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
29 Jul 2018
•
17mins
Raymond K. Cross, MD, MS: Case Discussion: The Moderate-to-severe CD patient: What are the options and where do new therapies including biosimilars fit in the picture?
Raymond K. Cross, MD, MS: Case Discussion: The Moderate-to-severe CD patient: What are the options and where do new therapies including biosimilars fit in the picture?
Webcast: Mastering Clinical Challenges and Emerging Therapies in IBD 2018
29 Jul 2018
•
17mins
